Characteristics associated with virologic failure in high-risk HIV-positive participants with prior failure: a post hoc analysis of ACTG 5251

References

• Walensky RP, Paltiel AD, Losina E, et al. The survival benefits of AIDS treatment in the United States. J Infec. Diseas. 2006;194(1):11–19.10.1086/jid.2006.194.issue-1
   PubMed Web of Science ®Google Scholar
• Palella FJ, Jr., Baker RK, Moorman AC, et al. Mortality in the highly active antiretroviral therapy era. J Acquir Immune Defic Syndr. 2006;43(1):27–34.10.1097/01.qai.0000233310.90484.16
   PubMed Web of Science ®Google Scholar
• Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. New England J Med. 2000;342(13):921–929.10.1056/NEJM200003303421303
   PubMed Web of Science ®Google Scholar
• Dieffenbach CW. Preventing HIV transmission through antiretroviral treatment-mediated virologic suppression. Curr Opin HIV AIDS. 2012;7(2):106–110.10.1097/COH.0b013e32834f3f13
   PubMed Web of Science ®Google Scholar
• Skarbinski J, Rosenberg E, Paz-Bailey G, et al. Human immunodeficiency virus transmission at each step of the care continuum in the United States. JAMA Internal Med. 2015;175(4):588–596.10.1001/jamainternmed.2014.8180
   PubMed Web of Science ®Google Scholar
• Gardner EM, McLees MP, Steiner JF, del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin. Infec. Diseas. 2011;52(6):793–800.10.1093/cid/ciq243
   PubMed Web of Science ®Google Scholar
• Mugavero MJ, Amico KR, Horn T, Thompson MA. The state of engagement in HIV care in the United States: From cascade to continuum to control. Clin. Infec. Diseas. 2013;57(8):1164–1171.10.1093/cid/cit420
   PubMed Web of Science ®Google Scholar
• Bradley H, Hall HI, Wolitski RJ, et al. Vital signs: HIV diagnosis, care, and treatment among persons living with HIV–United States, 2011. MMWR Morb Mortal Wkly Rep. 2014;63(47):1113–17.
   PubMed Web of Science ®Google Scholar
• Hull MW, Montaner JS. HIV treatment as prevention: The key to an AIDS-free generation. J Food Drug Anal. 2013;21(4):S95–S101.10.1016/j.jfda.2013.09.043
   PubMed Web of Science ®Google Scholar
• Needle R, Fu J, Beyrer C, et al. PEPFAR’s evolving HIV prevention approaches for key populations—people who inject drugs, men who have sex with men, and sex workers. J Acquir Immune Defic Syndr. 2012;60(Suppl 3):S145–S151.10.1097/QAI.0b013e31825f315e
   PubMed Web of Science ®Google Scholar
• The Office of the Global AIDS Coordinator. PEPFAR BluePrint: Creating an AIDS-free Generation. 2012. http://www.pepfar.gov/documents/organization/201386.pdf.
   Google Scholar
• Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-infected Adults and Adolescents. Department of Health and Human Services. http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.
   Google Scholar
• Mbuagbaw L, Sivaramalingam B, Navarro T, et al. Interventions for enhancing adherence to antiretroviral therapy (ART): A systematic review of high quality studies. AIDS Patient Care STDs. 2015;29(5):248–266.10.1089/apc.2014.0308
   PubMed Web of Science ®Google Scholar
• Blashill AJ, Bedoya CA, Mayer KH, et al. Psychosocial syndemics are additively associated with worse ART adherence in HIV-infected individuals. AIDS Behav. 2015;19(6):981–986.10.1007/s10461-014-0925-6
   PubMed Web of Science ®Google Scholar
• Castillo-Mancilla JR, Cohn SE, Krishnan S, et al. Minorities remain underrepresented in HIV/AIDS research despite access to clinical trials. HIV Clin Trials. 2014;15(1):14–26.10.1310/hct1501-14
   PubMed Web of Science ®Google Scholar
• Robbins GK, Johnson KL, Chang Y, et al. Predicting virologic failure in an HIV clinic. Clin Infect Dis. 2010;50(5):779–86.
   PubMed Web of Science ®Google Scholar
• Collier AC, Ribaudo H, Mukherjee AL, et al. A randomized study of serial telephone call support to increase adherence and thereby improve virologic outcome in persons initiating antiretroviral therapy. J Infec. Diseas. 2005;192(8):1398–1406.10.1086/jid.2005.192.issue-8
   PubMed Web of Science ®Google Scholar
• Reynolds NR, Testa MA, Su M, et al. Telephone support to improve antiretroviral medication adherence. J Acquir Immune Defic Syndr. 2008;47(1):62–68.10.1097/QAI.0b013e3181582d54
   PubMed Web of Science ®Google Scholar
• Robbins GK, Testa MA, Su M, et al. Site nurse–initiated adherence and symptom support telephone calls for HIV-positive individuals starting antiretroviral therapy, ACTG 5031: Substudy of ACTG 384. HIV Clin Trials. 2013;14(5):235–253.10.1310/hct1405-235
   PubMed Web of Science ®Google Scholar
• Miller WR, Rollnick S. Motivational Interviewing. 2nd ed. New York, NY: The Guilford Press; 2002.
   Google Scholar
• Leventhal H, Meyer D, Nerenz D. The common sense representation of illness danger. Contrib Med Psychol. 1980;2:7–30.
   Google Scholar
• Leventhal H, Diefenbach M, Leventhal EA. Illness cognition: Using common sense to understand treatment adherence and affect cognition interactions. Cognitive Ther Res. 1992;16(2):143–163.10.1007/BF01173486
   Web of Science ®Google Scholar
• Reynolds NR. The problem of antiretroviral adherence: A self-regulatory model for intervention. AIDS Care. 2003;15(1):117–124.10.1080/0954012021000039815
   PubMed Web of Science ®Google Scholar
• Weinman J, Petrie KJ, Moss-Morris R, Horne R. The illness perception questionnaire: A new method for assessing the cognitive representation of illness. Psychol Health. 1996;11(3):431–445.10.1080/08870449608400270
   Web of Science ®Google Scholar
• Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385–401.10.1177/014662167700100306
   Web of Science ®Google Scholar
• Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. AIDS Care. 2000;12(3):255–266.10.1080/09540120050042891
   PubMed Web of Science ®Google Scholar
• Broadbent E, Petrie KJ, Main J, Weinman J. The brief illness perception questionnaire. J Psychosom Res. 2006;60(6):631–637.10.1016/j.jpsychores.2005.10.020
   PubMed Web of Science ®Google Scholar
• Walsh JC, Mandalia S, Gazzard BG. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS. 2002;16(2):269–277.10.1097/00002030-200201250-00017
   PubMed Web of Science ®Google Scholar